Dashboard
Manage Tickers

RDHLRedHill Biopharma Ltd.

Nasdaq redhillbio.com


$ 7.58 $ -0.87 (-10.32 %)    

Tuesday, 27-Aug-2024 15:59:06 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 471.00 $ -5.74 (-1.2 %)
DIA $ 410.92 $ -1.71 (-0.41 %)
SPY $ 557.50 $ -3.66 (-0.65 %)
TLT $ 97.92 $ -0.09 (-0.09 %)
GLD $ 231.58 $ -0.23 (-0.1 %)
$ 7.56
$ 6.97 x 100
-- x --
-- - --
$ 6.43 - $ 82.00
115,215
na
385.46M
$ 1.38
$ 16.12
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

redhill-biopharma-says-fda-granted-orphan-drug-designation-to-opaganib-for-treatment-of-neuroblastoma-a-type-of-childhood-cancer
RedHill Biopharma Says FDA Granted Orphan-...
08/26/2024 11:11:29

Orphan Drug designation provides for a seven-year marketing exclusivity period should opaganib be approved in neuroblastoma and...

redhill-biopharma-launched-talicia-omeprazole-magnesium-amoxicillin-and-rifabutin-in-the-united-arab-emirates-making-it-available-by-prescription-to-treat-adults-with-helicobacter-pylori-infection
Redhill Biopharma Launched Talicia (Omepra...
08/21/2024 11:25:54

The commercial launch of Talicia in the UAE triggers RedHill's eligibility for additional potential milestone payments, min...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
08/20/2024 12:55:07

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
08/19/2024 23:50:04

israel-based-redhills-investigational-covid-19-treatment-shows-encouraging-action-in-obesity-and-diabetes
Israel-Based RedHill's Investigational COV...
08/19/2024 12:56:58

RedHill Biopharma released study results showing opaganib's potential in treating Type 2 diabetes and obesity. The drug'...

redhill-biopharmas-opaganib-demonstrates-impact-on-weight-and-glucose-in-preclinical-studies
RedHill Biopharma's Opaganib Demonstrates ...
08/19/2024 11:05:03

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today...

redhill-biopharma-announces-plan-to-implement-ads-ratio-change-for-the-exchange-of-every-twenty-five-existing-ads-held-for-one-new-ads
Redhill Biopharma Announces Plan To Implem...
08/16/2024 11:07:29

crude-oil-moves-lower-moderna-shares-plunge
Crude Oil Moves Lower; Moderna Shares Plunge
08/01/2024 18:34:37

dow-dips-over-500-points-ism-manufacturing-pmi-falls-in-july
Dow Dips Over 500 Points; ISM Manufacturin...
08/01/2024 16:06:46

nasdaq-surges-1-meta-posts-upbeat-earnings
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
08/01/2024 14:15:23

redhill-biopharma-announced-new-publication-of-data-showing-that-triple-antimicrobial-therapy-with-rhb-104-plus-standard-of-care-targeting-mycobacterium-avium-subspecies-paratuberculosis-is-64-more-effective-than-soc-alone-in-crohns-disease
RedHill Biopharma Announced New Publicatio...
08/01/2024 11:43:38

redhill-biopharma-terminates-agreement-with-movantik-acquisition-valinor-pharma-and-hcr-redhill-and-received-99m-in-cash-and-gained-full-control-over-an-additional-074m-currently-held-in-restricted-account
Redhill Biopharma Terminates Agreement Wit...
07/22/2024 11:14:53

In addition, the Agreement ends all existing credit ties with the Agreement parties, removes the existing lien against Talicia®...

redhill-biopharma-terminates-license-agreement-for-aemcolo-a-treatment-for-travelers-diarrhea-will-be-officially-terminated-on-october-8-2024
RedHill Biopharma Terminates License Agree...
07/09/2024 12:12:32

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 20:31:14

redhill-biopharma-has-received-a-notice-of-allowance-for-its-us-patent-application-17900235-titled-biomarkers-of-coronavirus-pneumonia-for-treating-coronavirus-infection-or-preventing-diseases-caused-by-coronavirus-infection
RedHill Biopharma Has Received A Notice Of...
06/18/2024 19:58:44

https://patentcenter.uspto.gov/applications/17900235/ifw/docs

redhill-biopharma-announced-new-chinese-patent-notice-of-allowance-for-opaganib-in-combination-with-immune-checkpoint-inhibitors-as-a-method-of-inducing-an-anti-cancer-immune-response-protecting-opaganibs-potential-use-through-2040
RedHill Biopharma Announced New Chinese Pa...
06/03/2024 11:05:33

redhill-announces-new-opaganib-chinese-patent-against-ebola-virus-valid-through-2035
RedHill Announces New Opaganib Chinese Pat...
05/06/2024 11:01:59

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today...

redhill-announces-first-patient-enrolled-in-us-government-supported-covid-19-study-of-rhb-107-upamostat-the-study-is-expected-to-be-completed-by-the-end-of-2024
RedHill Announces First Patient Enrolled i...
04/24/2024 11:06:57

redhill-biopharma-fy23-eps-001-up-from-012-yoy-revenue-65m-down-from-618m-yoy
RedHill Biopharma FY23 EPS $0.01 Up From $...
04/08/2024 13:26:55

redhill-biopharma-announces-125m-registered-direct-offering-at-a-premium-to-market-price
RedHill Biopharma Announces $1.25M Registe...
04/02/2024 11:10:00

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION